Rakovina Therapeutics and Celvion Therapeutics Partner for AI-Driven Cancer Drug Development

This partnership leverages AI and real-world clinical data to advance precision medicine in cancer treatment, showcasing beneficial applications of AI in healthcare.

Auto-scored: The event involves a positive medical use of AI with minimal risk and represents a partial step in mitigation.